REVIEW article
Front. Cell Dev. Biol.
Sec. Embryonic Development
Volume 13 - 2025 | doi: 10.3389/fcell.2025.1619050
This article is part of the Research TopicProceedings of Anatomy 2024 – Tripartite Meeting: The Role of Medical Embryology for Interdisciplinary ResearchView all 4 articles
The Future of Embryo Engineering and Fertility Research in Interdisciplinary Collaboration
Provisionally accepted- Wroclaw Medical University, Wrocław, Poland
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The increasing prevalence of marital infertility and the persistent desire for offspring have become more significant issues over past decades. Considering the potential genetic, hormonal, and anatomical causes, it is evident that the analysis of infertility is complex, necessitating the development of innovative therapies to address various challenges and dilemmas. The interdisciplinary collaboration of multiple fields fosters scientific progress, such as the development of new research models, reproductive mini-organoids, enhancing the chances of successful parenthood even in challenging cases. Since the fifth decade of the 20th centurymarked by the in vitro fertilization of an egg cell, the birth of Louise Brown (the first test-tube baby), the methods of embryo cryopreservation, the discovery of induced pluripotent stem cells (iPSC), and the genetic editing technology CRISPR-Cas9-research has been advancing towards promising directions for studying infertility causes and testing potential therapeutic interventions in controlled conditions. Gene therapy stands as a significant pillar, with 2017 witnessing promising experimental advancements in repairing mutations responsible for hypertrophic cardiomyopathy. Attempts were also made to create Human Immunodeficiency Virus (HIV) immunity by disabling the CCR5 gene, leading to the birth of twins with this variation. Progress in innovative therapies has kept pace with advancements in artificial intelligence, poised to revolutionize reproductive medicine by minimizing human errors. Machine learning (ML) algorithms are being integrated into embryo selection processes, predicting their implantation potential, raising concerns among various nations about eugenics and the interference with human nature. These concerns form a highly debated legal and political pillar. The growing automation is driven by arguments related to the increasing problems of future challenges, such as environmental changes or declining gamete quality. Scenarios under consideration include the development of advanced assisted reproduction technologies and support programs. Theoretical possibilities of alternative methods for organism development are being explored, though they remain constrained by the necessity of rigorous human studies.
Keywords: embryo engineering, Infertility, interdisciplinarity, Gene Therapy, Future development
Received: 27 Apr 2025; Accepted: 14 Aug 2025.
Copyright: © 2025 Soczyńska, Gawełczyk, Papierkowska, Muzyka, Majcherczyk, Obrycka, Żołyniak and Wozniak. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Julia Soczyńska, Wroclaw Medical University, Wrocław, Poland
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.